Chat with us, powered by LiveChat

March 2025

Advancing drug discovery though data-driven federated learning

A new paper, “Data-driven federated learning in drug discovery with knowledge distillation”, was recently published in Nature Machine Intelligence, the leading journal for Machine Learning and AI. It explores the potential for federated learning to advance drug discovery through secure, collaborative research, representing a major step forward in privacy-preserving machine learning.   What is Federated […]

Advancing drug discovery though data-driven federated learning Read More »

Blog image for how to overcome challenges in forced degradation studies with Zeneth

How to overcome the critical challenges faced in forced degradation studies

At Lhasa we know that there are many challenges involved in carrying out risk assessments for drug substances and drug products, to ultimately ensure a safe and effective product for patients. Forced degradation studies are essential in pharmaceutical development to assess drug stability and ensure product quality and safety. These studies help identify degradation pathways,

How to overcome the critical challenges faced in forced degradation studies Read More »

Anvisa rdc 964/2025 update blog image of logo

Anvisa RDC 964/2025: What you need to know about the latest regulatory update

The Brazilian Health Regulatory Agency (Anvisa) has introduced RDC 964/2025, a new guidance that outlines in more detail the requirements for conducting forced degradation studies. This new regulation replaces RDC 53/2015, aligning the requirements for forced degradation studies with international (ICH) standards. By reacting to these regulatory changes, Lhasa has evolved our solution for predicting

Anvisa RDC 964/2025: What you need to know about the latest regulatory update Read More »